Association between depression and cardiometabolic multimorbidity: A protocol for a systematic review and meta-analysis
PLOS One · 2026
DOI: 10.1371/journal.pone.0352464 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS One, 2026. Verfasst von Myo Zin Oo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand. Hauptthemen laut MEDLINE: Depression, Cardiovascular Diseases, Multimorbidity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Introduction
Cardio metabolic multimorbidity (CMM) is increasingly prevalent and associated with substantial morbidity and mortality, yet the role of depression in the clustering of cardiometabolic conditions has not been comprehensively synthesized. This systematic review and meta-analysis aims to synthesize observational evidence on the association between depression and cardiometabolic multimorbidity and to estimate the prevalence of cardiometabolic multimorbidity among adults with depression.
Methods
The protocol was registered in PROSPERO (CRD420251079959) and is reported in accordance with PRISMA-P guidelines. We will include observational studies (cohort, case-control, and cross-sectional) involving adults aged ≥18 years that examine the association between depression and CMM. Depression must be assessed using validated diagnostic criteria, standardized screening instruments, or clinical codes. CMM will be defined as the coexistence of two or more cardiometabolic diseases, including at least one metabolic and one cardiovascular condition. Relevant studies will be identified through systematic searches of PubMed, Embase, and Scopus from inception to September 2026, without language restrictions. Two reviewers will independently screen studies, extract data, and assess risk of bias using the Newcastle-Ottawa Scale (NOS) for cohort and case-control studies and the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for cross-sectional studies. Random-effects meta-analyses will be conducted to pool adjusted association estimates. Where sufficient longitudinal data are available, longitudinal risk estimates will also be synthesized separately. Pooled prevalence of CMM among individuals with depression will also be estimated. Heterogeneity, publication bias, and subgroup analyses according to age, sex, geographic region, depression ascertainment method, and cardiometabolic multimorbidity definition will be conducted where sufficient data are available. Certainty of evidence will be evaluated using the GRADE approach.
Conclusion
This systematic review and meta-analysis is expected to improve the understanding of the relationship between depression and cardiometabolic multimorbidity and to inform future research, clinical practice, and public health strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
- Global Health and Chronic Conditions Research Center, Chiang Mai University, Chiang Mai, Thailand.
- Department of Family Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
- College of Public Health Sciences, Chulalongkorn University, Bangkok, Thailand.
ORCID-Profile: Myo Zin Oo
Zitieren
APA
Oo, M. Z., Tint, S. S., & Bodhisane, S. (2026). Association between depression and cardiometabolic multimorbidity: A protocol for a systematic review and meta-analysis. PLOS One. https://doi.org/10.1371/journal.pone.0352464
Vancouver
Oo MZ, Tint SS, Bodhisane S. Association between depression and cardiometabolic multimorbidity: A protocol for a systematic review and meta-analysis. PLOS One. 2026. doi:10.1371/journal.pone.0352464
BibTeX
@article{Oo2026,
author = {Oo, Myo Zin and Tint, Soe Sandi and Bodhisane, Somdeth},
title = {Association between depression and cardiometabolic multimorbidity: A protocol for a systematic review and meta-analysis},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0352464}
}
EUVIMED